 The primary objective is to evaluate the hypnotic efficacy of zolpidem-MR modified release 12.5 mg and zolpidem 10 mg marketed product in comparison with placebo in patients with primary insomnia and sleep maintenance difficulties, using polysomnography PSG recordings and patient sleep questionnaires. 